|
|
|
|
|
by kdamica
358 days ago
|
|
Hard disagree with this. Unlike medical experiments, the cost of being wrong startup experiments is very low: you thought there was a small effect and there was none. It’s usually just a matter of pushing one variant vs another and moving on. There are certainly scenarios where more rigor is appropriate, but usually those come from trying to figure out why you’re seeing a certain effect and how that should affect your overall company strategy. My advice for startups is to run lots of experiments, do bad statistics, and know that you’re going to have some false positives so that you don’t take every result as gospel. |
|